Fig. 5
From: Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Neuropathological comorbidities associated with the clinical progression of dementia with Lewy bodies (DLB) or progression of premotor Parkinson’s disease (Pm-PD) to Parkinson’s disease (PD) and in a subset of individuals to Parkinson’s disease dementia (PDD). Clinical progression is depicted as increasing darkness of blue. Braak stage of Lewy pathology is depicted in green, frequency ad severity of Alzheimer’s disease (AD) pathology is depicted in yellow and frequency of TAR DNA-binding protein 43 (TDP-43)) pathology in orange